Literature DB >> 19786652

Relapse/Refractory myeloma patient: potential treatment guidelines.

Jesús F San Miguel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19786652     DOI： 10.1200/JCO.2009.24.3683

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma.

Authors:  Nilanjan Ghosh; Noah Tucker; Marianna Zahurak; Jocelyn Wozney; Ivan Borrello; Carol Ann Huff
Journal:  Am J Hematol       Date:  2014-04-26       Impact factor: 10.047

Review 2.  Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity.

Authors:  R F Cornell; A A Kassim
Journal:  Bone Marrow Transplant       Date:  2016-01-04       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.